Calpains are Ca 2+ -dependent intracellular proteases. We show here that calpain-generated natural C-terminal fragments of proteins that include G protein-coupled receptors, transmembrane ion channels, transcriptional regulators, apoptosis controllers, kinases, and phosphatases (Phe-GluN2a, Lys-Ica512, Arg-Ankrd2, Tyr-Grm1, Arg-Atp2b2, Glu-Bak, Arg-Igfbp2, Glu-IκBα, and Arg-cFos), are short-lived substrates of the Arg/N-end rule pathway, which targets destabilizing N-terminal residues. We also found that the identity of a fragment's N-terminal residue can change during evolution, but the residue's destabilizing activity is virtually always retained, suggesting selection pressures that favor a short half-life of the calpain-generated fragment. It is also shown that a self-cleavage of a calpain can result in an N-end rule substrate. Thus, the autoprocessing of calpains can control them by making active calpains short-lived. These and related results indicate that the Arg/N-end rule pathway mediates the remodeling of oligomeric complexes by eliminating protein fragments that are produced in these complexes through cleavages by calpains or other nonprocessive proteases. We suggest that this capability of the Arg/N-end rule pathway underlies a multitude of its previously known but mechanistically unclear functions.
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proteolysis | calpain substrates | ubiquitin C alpains are a family of intracellular proteases that have in common their dependence on Ca 2+ , their belonging to the superfamily of cysteine proteases, and their ability to make a small number of specific cuts in their natural protein substrates (1) (2) (3) . Of the 14 distinct human calpains, the ubiquitously expressed calpain-1 (μ-calpain) and calpain-2 (m-calpain) are the major species. Natural calpain substrates were identified thus far largely by serendipity, as distinguished from proteome-scale surveys. The number of known calpain substrates in mammals is roughly 200. Calpain-mediated cuts have been accurately mapped in fewer than 100 of these proteins. The actual diversity of calpain substrates encoded by a mammalian genome is unknown. It may significantly exceed 1,000 different proteins (2) .
The functions of calpains are many and stem from calpainmediated cleavages of specific proteins at defined positions, usually within unstructured loops (1, 2) . These cleavages are controlled by the levels of Ca 2+ , by phosphorylation of calpains and/or their substrates, by natural calpain inhibitors such as calpastatin (4) , and by a regulated localization (e.g., membrane localization) of specific calpains. For example, cell movements involve calpain-mediated, spatiotemporally controlled cleavages of cytoskeletal proteins (5) . Proteolysis by calpains plays many other roles as well, including their major functions in the brain and muscle (6) (7) (8) . Despite the obvious biological importance of calpains, the functional understanding of calpain-generated specific protein fragments and their effects on oligomeric protein complexes (in which these fragments are formed and initially reside) is just beginning.
In vivo cleavages of cytosolic and nuclear proteins by nonprocessive proteases such as separases, caspases, and (some) deubiquitylases can generate C-terminal fragments that bear destabilizing N-terminal residues, i.e., the ones that can be recognized by the N-end rule pathway, a processive proteolytic system. These fragments have been shown to be short-lived N-end rule substrates, with either demonstrated or predicted functional ramifications (9) (10) (11) (12) (13) (14) . In the present work, we extended these insights to a number of natural calpain substrates, thereby linking the N-end rule pathway to biological consequences of calpain activity.
The N-end rule pathway recognizes proteins containing N-terminal degradation signals called N-degrons, polyubiquitylates these proteins, and thereby causes their degradation by the proteasome ( Fig. 1) (9, 11, 12, (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . The main determinant of an N-degron is a destabilizing N-terminal residue of a protein.
Recognition components of the N-end rule pathway are called N-recognins. In eukaryotes, N-recognins are E3 ubiquitin (Ub) ligases that can target N-degrons ( Fig. 1) .
Regulated degradation of proteins or their fragments by the N-end rule pathway mediates a strikingly broad range of biological functions, including the sensing of heme, NO, oxygen, and short peptides; the control, through subunit-selective degradation, of the input stoichiometries of subunits in oligomeric protein complexes; the elimination of misfolded or otherwise abnormal proteins; the degradation of specific proteins after their retrotranslocation to the cytosol from mitochondria or other membrane-enclosed compartments; the repression of apoptosis and neurodegeneration; the regulation of chromosome transcription, repair, replication, and cohesion/segregation; the regulation of G proteins, autophagy, peptide import, meiosis, immunity, fat metabolism, cell migration, actin filaments, cardiovascular development, spermatogenesis, neurogenesis, and memory; and the regulation of many processes in plants ( Fig. 1 and SI Text).
In eukaryotes, the N-end rule pathway consists of two branches. One of them, called the Arg/N-end rule pathway, targets specific unacetylated N-terminal residues (Fig. 1A) (11, 15, 23) . The primary destabilizing N-terminal residues Arg, Lys, His, Leu, Phe, Tyr, Trp, and Ile are directly recognized by N-recognins. In contrast, N-terminal Asn, Gln, Asp, and Glu (as well as Cys under some metabolic conditions) are destabilizing owing to their preliminary enzymatic modifications, which include Nt-deamidation and Ntarginylation (Fig. 1A) . In the yeast Saccharomyces cerevisiae, the Arg/N-end rule pathway is mediated by the Ubr1 N-recognin, a 225-kDa RING-type E3 Ub ligase and a part of the targeting complex comprising the Ubr1-Rad6 and Ufd4-Ubc4/5 holoenzymes (9, 16, 19) . In multicellular eukaryotes, several E3 Ub ligases (including Ubr1) function as N-recognins of the Arg/N-end rule pathway (Fig. 1A) . It was recently shown that both yeast and mammalian Ubr1 can recognize not only the unacetylated primary destabilizing N-terminal residues cited above, but also the unacetylated N-terminal Met residue, if it is followed by a hydrophobic residue. This capability of the Arg/N-end rule pathway greatly expands the range of its substrates, as virtually all nascent proteins bear N-terminal Met (23) .
The other branch, called the Ac/N-end rule pathway, recognizes proteins through their N α -terminally acetylated (Nt-acetylated) residues (Fig. 1B) (17, 23, 24) . The degradation signals and E3 Ub ligases of the Ac/N-end rule pathway are called Ac/N-degrons and Ac/N-recognins, respectively. Nt-acetylation of cellular proteins is apparently irreversible, in contrast to acetylation-deacetylation of internal Lys residues. The bulk of Nt-acetylation is cotranslational, being mediated by ribosome-associated Nt-acetylases. Approximately 90% of human proteins are Nt-acetylated (25, 26) . Many, possibly most, Nt-acetylated proteins contain Ac/N-degrons (Fig. 1B) (17, 23, 24) .
Our surveys of the previously characterized natural calpain substrates in mammals identified ∼50 proteins (about 40% of the total number of actually mapped substrates) whose calpaingenerated C-terminal fragments bear destabilizing N-terminal residues recognized by the Arg/N-end rule pathway. These proteins include transcriptional and translational regulators, transmembrane ion channels, cytoskeletal proteins, kinases, phosphatases, and other enzymes (Fig. 2) . We selected from this set, essentially at random, 11 natural fragments (Phe1279-GluN2a, Lys609-Ica512, Arg103-Ankrd2, Tyr937-Grm1, Arg1091-Atp2b2, Glu16-Bak, Arg181-Igfbp2, Glu51-IκBα, Arg91-c-Fos, Asp142-Capns1, and Leu28-Capn1) (Fig.  2, #1 and #4-13) and examined them for actually being N-end rule substrates. It should be noted that none of the earlier studies that initially described these or other calpain-generated protein fragments considered the possibility of their regulation through degradation by the N-end rule pathway.
We show here that all of these fragments are, in fact, short-lived substrates of the Arg/N-end rule pathway. As discussed below, calpains join other proteases, including Met-aminopeptidases, separases and caspases, as substrate-generating upstream components of the Arg/N-end rule pathway (Fig. 1A) . Specifically, cleavages by these and other nonprocessive proteases can produce protein-size fragments that bear active N-degrons. We discuss the biological ramifications of this advance and the resulting connection between the Arg/N-end rule pathway and the functions of calpains.
Results
Destabilizing N-Terminal Residues of Calpain-Generated Fragments.
A P1′ residue of a cleavage site is the residue that becomes N-terminal upon cleavage. The identities of P1′ residues in full-length proteins that give rise to the Arg91-c-Fos, Lys609-Ica512, Arg1091-Atp2b2, and Leu28-Capn1 fragments were unchanged during evolution of examined vertebrates (Fig. S1 A, B, D, and E). In contrast, N-terminal Arg of the Arg103-Ankrd2 fragment is conserved among mammals and birds but changes to Lys in amphibians (Fig. 3E) . N-terminal Glu of Glu16-Bak is conserved in humans, dogs, cows, and bats, but changes to Asp in hamsters and manatees and to Lys in armadillos and bonobos (Pan paniscus), a species of chimpanzee (Fig. 3A) . Remarkably, this residue of Bak is Glu (i.e., the same as in human Glu16-Bak) in the other chimpanzee species, Pan troglodytes, strongly suggesting that the Glu16→Lys16 mutation in Bak of P. paniscus occurred after divergence of these chimpanzee lineages, i.e., less than 2 Mya (Fig. 3A) . N-terminal Asp of Asp143-Capns1 is conserved in vertebrates other than fishes but changes to Glu in fishes (Fig. 3F) . N-terminal Arg of Arg181-Igfbp2 is conserved from mammals to fishes but changes to Lys in lizards (Fig. S1C) . N-terminal Glu of Glu51-IκBα is conserved among mammals and fishes but changes to Asp in chickens and to Asn in amphibians (Fig. 3C) . N-terminal Tyr of Tyr937-Grm1 is conserved in most vertebrates but changes to Phe in armadillos and to His in Jaculus, a family of small rodents (Fig. 3B) . N-terminal Phe of mouse Phe1279-GluN2a changes to Leu in humans, cows, and platypuses, to Tyr in chickens, and to His in turtles (Fig. 3D) . Calpain-generated C-terminal fragments of mammalian proteins that are identified or predicted substrates of the Arg/N-end rule pathway. The entries whose numbers are in green are the experimentally characterized and validated (most of them in the present study) substrates of the Arg/N-end rule pathway. The entries whose numbers are in black are predicted Arg/N-end rule substrates. Each entry cites a calpain-generated C-terminal fragment of a protein and the fragment's N-terminal residue (using three-letter abbreviations for amino acids), followed by a description of uncleaved (full-length) precursor protein. A calpain cleavage site, denoted by an arrowhead, is denoted using single-letter abbreviations for amino acids. An enlarged P1′ residue (in red) becomes N-terminal on the cleavage. The indicated residue numbers are the number of the first shown residue of a full-length protein and the number of its last residue, respectively. All entries are mouse proteins, with the exception of #14 and #27, which are human proteins. See SI Text for a detailed supplementary legend to this data-rich figure.
Remarkably, this seeming jumble of evolutionary changes of P1′ residues in calpain substrates ( Fig. 3 and Fig. S1 ) exhibits a telling constraint: all of the above P1′ residues (future N-terminal residues), including the ones that became altered during evolution, are destabilizing in the Arg/N-end rule pathway (Fig.  1A) . In other words, the observed changes of P1′ residues in these calpain substrates always retained the ability of a fragment's N-terminal residue to be targeted by the Arg/N-end rule pathway (Figs. 1A and 3 and Fig. S1 ). A constraint of this kind would be expected if a short in vivo half-life of a fragment (rather than the exact identity of its N-terminal residue) is a fitnessincreasing property of this fragment, favored by natural selection.
Calpain-Generated Protein Fragments as N-End Rule Substrates.
Previous analyses of cleavage sites in calpain substrates were performed in vitro, using purified calpains and (usually) higher concentrations of Ca 2+ than the physiologically relevant (low micromolar) calpain-activating levels of Ca 2+ . These analyses indicated that some proteins can be cleaved in vitro by calpains at multiple sites (typically two, occasionally three or more). In such cases only one, usually the predominant site, was examined in the present study (Figs. 4 and 5) . In vivo, the same proteins would encounter lower levels of calpains and lower durations of calpain-activating concentrations of Ca 2+ . In addition, natural calpain substrates are usually subunits of oligomeric complexes. For all these reasons, calpain-mediated cleavages of proteins in vivo are likely to be more confined in extent and scope than the observed in vitro cleavages. Having mentioned limitations of in vitro analyses, we should emphasize that all calpain-generated fragments cited in Fig. 2 have been detected in vivo as well (Introduction). The N-end rule degradation assays used the Ub reference technique (URT) (Fig. 4A) (27) . The cotranslational cleavage of a URT-based fusion by deubiquitylases produces, at the initially equimolar ratio, a test protein with a desired N-terminal residue and a reference protein such as f DHFR-Ub R48 , a flag-tagged derivative of dihydrofolate reductase (Fig. 4A) . In URT-based assays, a labeled test protein is quantified by measuring its level relative to the level of a stable reference at the same time point (12, 14) .
URT-based 35 S-pulse-chases were performed in a transcription-enabled rabbit reticulocyte extract, which has been extensively used to analyze the Arg/N-end rule pathway (9) . Specific URT fusions were labeled with 35 S-Met/Cys for 10 min at 30°C, followed by a chase, immunoprecipitation with anti-flag antibody, SDS/PAGE, autoradiography, and quantification (Figs. 4 and 5) . The logic of these assays involves a comparison between the degradation rates of a protein bearing a destabilizing N-terminal residue and an otherwise identical protein with an N-terminal residue such as Val, which is not recognized by the Arg/N-end rule pathway (Fig. 1A) . In addition to being more accurate than pulse-chases without a stable reference, URT makes it possible to measure the degradation of a test protein during the pulse, i.e., before the chase (12, 14) .
Phe1279-GluN2a. GluN2a (NMDA-R2a) is a subunit of the NMDA receptor (NMDAR), a glutamate receptor that can function as a ligand-gated Ca 2+ channel (28) . The 23-kDa calpain-generated mouse Phe1279-GluN2a fragment (Figs. 2, #13 , and 3D) (29) was short-lived in reticulocyte extract (initial postpulse t 1/2 of ∼8 min), in striking contrast to the otherwise identical Val1279-GluN2a fragment, which was nearly completely stable (Fig. 4 B and C) . Moreover, ∼90% of 35 S-labeled Phe1279-GluN2a was degraded by the Arg/N-end rule pathway before the chase (during the 10-min pulse), in contrast to Val1279-GluN2a (Fig. 4C) . Lys609-Ica512. Ica512 (Ptprn) is a member of the receptor protein phosphatase (PTP) family of integral membrane proteins, except that the cytosolic domain of Ica512 lacks phosphatase activity (30) . Ica512 is expressed largely in neurons and neuroendocrine cells and is a major target of autoreactive antibodies in type I diabetes. The 43-kDa calpain-generated mouse Lys609-Ica512 fragment (Fig. 2, #12 , and Fig. S1D ) enters the nucleus and acts as a transcriptional regulator (30, 31) . Lys609-Ica512 was shortlived in reticulocyte extract (postpulse t 1/2 of ∼6 min), in contrast to Val609-Ica512, which was completely stable (Fig. 4 D and E) . Moreover, ∼75% of 35 S-labeled Lys609-Ica512 was degraded before the chase, in contrast to Val609-Ica512 (Fig. 4E) . Arg103-Ankrd2. Ankrd2 (Marp2, Arpp) is a member of the MARP (muscle ankyrin repeat protein) family. Ankrd2 is preferentially expressed in the skeletal and cardiac muscle and functions as a negative regulator of muscle differentiation (32) . The 30-kDa calpain-generated mouse Arg103-Ankrd2 fragment (Figs. 2, #10, and 3E) (33) was short-lived in reticulocyte extract (initial postpulse t 1/2 of ∼5 min), in contrast to Val103-Ankrd2, which was nearly completely stable (Fig. 4 F and G). In addition, ∼94% of 35 S-labeled Arg103-Ankrd2 was degraded by the Arg/N-end rule pathway before the chase, in contrast to Val103-Ankrd2 (Fig. 4G ). Tyr937-Grm1. Grm1 (mGluR1α, mGlu1α) is an isoform of a member of the group I subfamily of metabotropic glutamate receptors (mGluRs). Grm1 is activated by glutamate, couples to G q -type G proteins, and mediates a variety of functions, including (indirectly) Ca 2+ transients (34) . The 30-kDa calpaingenerated mouse Tyr937-Grm1 fragment (Figs. 2, #11, and 3B) (35) was short-lived in reticulocyte extract (postpulse t 1/2 of ∼45 min), in contrast to Val937-Grm1, which was stable ( Fig. 4 H and I). One illustration of differences among the proteins characterized in this study was the slower (but still entirely N-end rule specific) degradation of Tyr937-Grm1, whose t 1/2 of ∼45 min ( Fig. 4 H and I) was at least fivefold longer than the half-lives of other calpain-generated Arg/N-end rule substrates (Fig. 4 B-G). In addition, little degradation of this fragment was observed before the chase (Fig. 4I) , in contrast to the massive prechase degradation (75-94%) of more unstable N-end rule substrates (Fig. 4 C, E, and G). Arg1091-Atp2b2. The plasma membrane Ca 2+ ATPase (PMCA) is a transmembrane pump that ejects Ca 2+ from the cytosol to extracellular space and is encoded by the functionally overlapping Atp2b1-Atp2b4 genes (36). The 13-kDa calpain-generated mouse Arg1091-Atp2b2 fragment (Fig. 2, #8 , and Fig. S1E) (37) was short-lived in reticulocyte extract (initial postpulse t 1/2 of ∼5 min), in contrast to Val1091-Atp2b2, which was nearly completely stable ( Fig. 4 J and K). In addition, ∼89% of 35 S-labeled Arg1091-Atp2b2 was degraded before the chase, in contrast to Val1091-Atp2b2 (Fig. 4K ). Glu16-Bak. Bak is a conditionally proapoptotic member of the Bcl-2 superfamily of apoptosis regulators. Owing to its C-terminal transmembrane domain, Bak resides in the outer mitochondrial and ER membranes. Under proapoptotic conditions, Bak contributes to the mitochondrial outer membrane permeabilization (MOMP), which can result in apoptosis (38) . The proapoptotic cleavage of Bak by calpains generates the 16-kDa Glu16-Bak fragment lacking the 15-residue N-terminal region of Bak that appears to interact with membranes in full-length Bak (39) . Mouse Glu16-Bak (Figs. 2, #1, and 3A) was short-lived in reticulocyte extract (initial postpulse t 1/2 of ∼20 min), in contrast to Val16-Bak, which was still unstable but to a much lower extent than Glu16-Bak (postpulse t 1/2 > 2 h), indicating the presence of a relatively weak internal degron ( Fig. 5 E and F) . In addition, ∼45% of 35 S-labeled Glu16-Bak was degraded before the chase, in contrast to Val16-Bak (Fig. 5F ). Arg181-Igfbp2. Insulin-like growth factor-binding proteins (IGFBPs) regulate insulin-like growth factors (IGFs) through interactions with IGFs that compete with their binding to IGF receptor. Although a large fraction of IGFBPs is extracellular, these proteins and their fragments have also been detected in the cytosol and the nucleus (40) . The 16-kDa mouse Arg181-Igfbp2 fragment (Fig. 2, #6 and Fig. S1C ) (41) was short-lived in reticulocyte extract (postpulse t 1/2 of ∼5 min), in contrast to Val181-Igfbp2, which was completely stable (Fig. 5 G and H) . In addition, ∼85% of 35 S-labeled Arg181-Igfbp2 was degraded before the chase, in contrast to Val181-Igfbp2 (Fig. 5) . Glu51-IκBα. IκBα binds to the multifunctional transcriptional regulator NFκB and retains it in the cytosol. The subunit-selective and conditional degradation of IκBα in the IκBα-NFκB complex activates NFκB (42) . The degradation of IκBα is mediated by two pathways, regulated by different inputs. Specifically, phosphorylation of IκBα activates its phosphodegron and results in its Ubdependent degradation by a pathway distinct from the N-end rule pathway. IκBα can also be cleaved by calpains, resulting in the 31-kDa Glu51-IκBα fragment (Figs. 2, #5, and 3C) (43) . Mouse Glu51-IκBα was short-lived in reticulocyte extract (postpulse t 1/2 of ∼14 min), in contrast to Val51-IκBα, which was nearly completely stable ( Autoprocessed Calpain Subunits as N-End Rule Substrates. Both Ca 2+ -activated calpain-1 (the catalytic subunit Capn1 plus the small subunit Capns1) and calpain-2 (Capn2 plus Capns1) can undergo a limited autoproteolysis (46, 47) . These N-terminal truncations of mouse Capn1, Capn2, and Capns1 generate, respectively, the Leu28-Capn1, Lys10-Capn2, and Asp142-Capns1 fragments, all of which bear destabilizing N-terminal residues (Figs. 1A, 2, #7, #9, and 3F and Fig. S1B ). Calpain autoproteolysis is illustrated in Fig.  S2D . Purified human calpain-1 was incubated in the presence of 40 μM CaCl 2 , followed by SDS/PAGE, which revealed the characteristic conversion of full-length Capn1 to a faster-migrating species (Fig. S2D) (47) . The D. melanogaster calpain-B can also be autoproteolyzed, resulting in the active Asn224-calpain-B fragment (48) bearing N-terminal Asn, a destabilizing residue (Fig. 1A) .
N-terminal autotruncations decrease the levels of Ca 2+ required for half-maximal calpain activity, a finding consistent with the possibility that autoproteolysis is functionally relevant (49) . In addition, autotruncations of calpains can also occur in living cells (50) . At the same time, other studies presented strong in vitro arguments that Ca 2+ -mediated activation of calpains does not require their autoproteolysis (1, 51) . If specific autotruncated calpain fragments were short-lived substrates of the Arg/N-end rule pathway, such a finding, in conjunction with the observed evolutionary conservation of the calpain auto-cleavage sites and P1′ residues ( Fig. 3F and Fig. S1B ), would suggest that the limited autoproteolysis of calpains is functionally relevant. Leu28-Capn1. Capn1 is the catalytic subunit of calpain-1. The 80-kDa autogenerated human Leu28-Capn1 fragment (Fig. 2, #9, and Fig. S1B ) (46) was degraded particularly rapidly either during or shortly after its synthesis (before the chase) in reticulocyte extract, and was moderately short-lived afterward (postpulse t 1/2 of ∼140 min), in contrast to Val28-Capn1, which was nearly completely stable ( Fig. 5 C and D) . Approximately 40% of 35 Slabeled Leu28-Capn1 was degraded before the chase, in contrast to Val28-Capn1 (Fig. 5D) . Asp142-Capns1. Capns1 is the noncatalytic subunit of calpain-1 and calpain-2. The 16-kDa calpain-generated mouse Asp142-Capns1 fragment (Figs. 2, #7 , and 3F) (52) was short-lived in reticulocyte extract (initial postpulse t 1/2 of ∼7 min), in contrast to Val142-Capns1, which was still unstable but much longer-lived (t 1/2 of ∼45 min; Fig. 5 A and B) . In addition, ∼70% of 35 S-labeled Asp142-Capns1 was degraded before the chase, in contrast to Val142-Capns1 (Fig. 5B) .
N-End Rule Substrate Produced by Calpain from a Full-Length Protein.
To probe degradation of a calpain-generated C-terminal fragment in living cells, we analyzed Phe1279-GluN2a. As described above, this fragment of a subunit of the NMDAR receptor was rapidly destroyed by the Arg/N-end rule pathway in reticulocyte extract (Figs. 2, #13, 3D, and 4 B and C). A URT-based pulsechase ( Fig. 4A ) in transfected HEK293T human cells produced similar results. Specifically, Phe1279-GluN2a was short-lived in HEK293T cells, in contrast to Val1279-GluN2a (Fig. S2 A and  B) . The latter fragment, although not as stable as it was in reticulocyte extract (Fig. 4 B and C) , was degraded in vivo much more slowly (t 1/2 > 2 h) than the otherwise identical Phe1279-GluN2a fragment (initial postpulse t 1/2 of ∼15 min; Fig. S2 A and  B) . Moreover, and also similarly to the results with reticulocyte extract, ∼70% of 35 S-labeled Phe1279-GluN2a was degraded before the chase (during the pulse), in contrast to Val1279-GluN2a ( Fig. S2 A and B) .
The Arg/N-end rule substrates examined thus far (Figs. 2-5 and Fig. S2A ) were produced through the Ub fusion technique, which makes it possible to form, cotranslationally, specific calpain-generated fragments without using calpains ( f Ica512 f -K609V was initiated by the addition of CaCl 2 and purified human calpain-1. After 30 min, the calpain inhibitor z-VF was added, followed by a chase for 30 and 120 min, immunoprecipitation with anti-flag antibody, SDS/PAGE, autoradiography, and quantification. The calpain-mediated cleavage of 35 Sf Ica512 f and f Ica512 f -K609V reached completion during the 30-min incubation with calpain-1 (Fig. 6B, lanes 2 and  6) . The relative stabilities of the resulting C-terminal fragments were as would be predicted from assays with Lys609-Ica512 vs. Val609-Ica512 that had been produced through the Ub fusion technique. Specifically, the calpain-generated Val609-Ica512 f fragment (produced from full-length f Ica512 f -K609V) was completely stable in reticulocyte extract, whereas the otherwise identical WT Lys609-Ica512 f was short-lived (t 1/2 of ∼40 min; Fig.  6 B and C). As could be expected, the posttranslationally generated (from full-length f Ica512 f ) Lys609-Ica512 f fragment was degraded less rapidly than the otherwise identical fragment that had been cotranslationally produced through the Ub fusion technique (Fig. 6 B and C vs. Fig. 4 D and E) .
To verify membrane localization of labeled 2 , and 50 μM A23184, a Ca 2+ ionophore. The cell-penetrating z-VF calpain inhibitor was then added, followed by a chase for 1.5 and 6 h, extraction of proteins, immunoprecipitation, SDS/PAGE, autoradiography, and quantification. The results were similar to those with reticulocyte extract, except for two differences (Fig. 6 D and E. vs. Fig. 6 B and C) . 
These assays confirmed that the degradation of a calpaingenerated C-terminal protein fragment that had been derived posttranslationally from a full-length precursor in reticulocyte extract or HEK293T cells was qualitatively similar to the degradation of the otherwise identical fragment that had been produced through the Ub fusion technique (Figs. 4-6 and Fig. S2 A  and B) . The cotranslationally generated Arg/N-end rule substrate such as Lys609-Ica512 was degraded faster than the otherwise identical substrate that had been produced posttranslationally (Fig. 4 D and E vs. Fig. 6 A-C) . These results were consistent with documented patterns of more efficacious degradation, by the Arg/N-end rule pathway, of conformationally immature proteins (9) .
Discussion
Previous studies have shown that C-terminal fragments of intracellular proteins that can be generated by separases and caspases often bear destabilizing N-terminal residues. As a result, these fragments can be recognized and degraded by the Arg/ N-end rule pathway (Fig. 1A) (9-13) .
For example, the high fidelity of chromosome cohesion/segregation in S. cerevisiae requires the destruction, by the Arg/ N-end rule pathway, of a C-terminal fragment of the Scc1/Rad21 subunit of cohesin, a protein whose ring-shaped molecules hold together sister chromatids (10) . The cleavage of Scc1, mediated by a protease called separase, opens the cohesin ring and allows separation of the chromatids. The normally short-lived C-terminal fragment of Scc1 becomes long-lived in ubr1Δ cells, which lack the Arg/N-end rule pathway. Ubr1-lacking cells exhibit a strikingly elevated frequency of chromosome loss. This genomic instability was traced to a long in vivo half-life of the normally short-lived C-terminal Scc1 fragment, whose increased levels in ubr1Δ cells impair chromosome mechanics (10) .
More recently, we discovered that the Arg/N-end rule pathway is also a functionally important repressor of apoptosis, through its ability to destroy and thereby to down-regulate a dozen or more of specific proapoptotic protein fragments that bear destabilizing N-terminal residues and are generated by activated caspases from full-length precursor proteins (11) . We also found that the previously identified, neurodegeneration-associated C-terminal fragments of Tau, Tdp43, and α-synuclein (these fragments are produced through cleavages by a variety of nonprocessive proteases) can be destroyed through their N-degrons, suggesting that one function of the Arg/N-end rule pathway is to counteract neurodegeneration (12) .
In the present study, the range of physiological Arg/N-end rule substrates was expanded to include a number of calpain-generated protein fragments that bear destabilizing N-terminal residues. We selected, nearly at random, 11 C-terminal fragments of natural calpain substrates from a larger set of such substrates whose fragments were predicted to bear N-degrons (Fig. 2 and the Introduction). All of the examined fragments were found to be efficacious targets of the Arg/N-end rule pathway. Moreover, in most of them, their N-degrons were, to a good approximation, either the sole or major degradation signals (Figs. 2 and 4-6 and Fig. S2 A and B) . Given these results, it is likely that many (possibly most) of the currently unverified calpain-generated protein fragments that are classed as predicted N-end rule substrates (Fig. 2, #14-34 ) will eventually prove to be such on direct examination.
The set of natural calpain-generated C-terminal protein fragments that have been identified in the present study as shortlived Arg/N-end rule substrates comprises Phe-GluN2a, the fragment of the subunit of the NMDAR; Lys-Ica512, the fragment of a receptor protein phosphatase-like protein; Arg-Ankrd2, the fragment of a negative regulator of muscle differentiation; Tyr-Grm1, the fragment of a metabotropic glutamate receptor; Arg-Atp2b2, the fragment of a transmembrane pump that ejects Ca 2+ from the cytosol; Glu-Bak, the proapoptotic fragment of an apoptosis regulator; Arg-Igfbp2, the fragment of an insulin-like growth factorbinding protein; Glu-IκBα, the fragment of the inhibitory subunit of the IκBα-NFκB complex; Arg-c-Fos, the fragment of a major transcriptional regulator; Leu28-Capn1, the autogenerated, catalytically active fragment of calpain-1; and Asp142-Capns1, the fragment of the noncatalytic subunit of calpain-1 (Figs. 2, #1 and #4-13, and 3-6 and Figs. S1 and S2).
Now that a number of functionally diverse proteins have been identified as precursors of calpain-generated fragments that are targeted for degradation by the Arg/N-end rule pathway (Figs. 2-6 ), the next step is to analyze the fragments themselves, their formation within cognate oligomeric complexes in vivo, the kinetics of fragments' degradation under physiologically relevant conditions, the remodeling of oligomeric complexes in which the fragments initially reside, and the functional significance of fragments vis-á-vis specific biological circuits that involve these (and analogous) fragments, as well as corresponding precursor proteins.
One verifiable possibility, stated here in the context of the IκBα precursor protein (Figs. 2, #5 , 3C, and 5 I and J) and likely to be relevant to other calpain substrates as well, is as follows. The calpain-mediated cleavage of IκBα, which yields the Glu51-IκBα fragment and the corresponding N-terminal fragment, may not suffice, by itself, for a rapid-enough in vivo dissociation of (at least) the Glu51-IκBα C-terminal fragment from the cleaved IκBα-NFκB complex. If so, the subunit selectivity of the Arg/ N-end rule pathway (9) that presumably involves a mechanochemical dislodging of the Glu51-IκBα fragment from the cleaved IκBα-NFκB complex before the fragment's processive degradation may be required for an optimal rate of liberation of the NFκB transcriptional activator. This rate would determine, in turn, the activity of NFκB circuits that involve the calpain-mediated cleavage of IκBα.
Both the proven examples above (the fidelity of chromosome segregation; the repression of apoptosis) and analogous but unexamined scenarios, such as the one about the Glu51-IκBα fragment, imply a mode of action by the Arg/N-end rule pathway that can recur in a broad variety of contexts. Confining this understanding to calpains, we suggest that the Arg/ N-end rule pathway can use its subunit selectivity (9, 53) to reset the state of a biological circuit by making possible an efficacious, degradation-mediated replacement of a cleaved subunit by the intact one in a protein complex that had sustained a calpain-mediated cleavage. If the efficacy of this subunit's replacement is a part of a circuit's output signal, the rate of degradation of a subunit's fragment by the Arg/N-end rule pathway may act as a timer, by analogy to other relatively slow and irreversible transitions, such as, for example, the hydrolysis of GTP by G-type proteins that mediates a variety of functions, from kinetic proofreading in protein synthesis to receptor desensitization.
Described in Results and illustrated in Fig. 3 and Fig. S1C are several examples of the "drift-with-constraint" evolutionary pattern of P1′ residues in calpain substrates (a P1′ residue becomes N-terminal upon cleavage of a polypeptide). For instance, the evolutionary changes of the P1′ residue in the cleavage site of Bak, a calpain substrate and regulator of apoptosis, are confined solely to Glu, Asp, and Lys, all of which are destabilizing residues (Figs. 1A and 3A) . These evolutionary patterns and the metabolic instability of the mouse Glu16-Bak fragment (Fig. 5 E and  F) strongly suggest that the degradation of this calpain-generated fragment serves to down-regulate its proapoptotic activity. The instability of proapoptotic Glu16-Bak that has been demonstrated in the present study is yet another illustration of the previously discovered function of the Arg/N-end rule pathway in which it acts as a repressor of apoptosis, by selectively destroying protease-generated proapoptotic protein fragments, the ones analogous to but distinct from Glu16-Bak (11).
We also found that the self-cleavages of calpain-1, either of its catalytic (Capn1) or noncatalytic (Capns1) subunits, yield C-terminal fragments (catalytically active in the case of Capn1) that are targeted for degradation by the Arg/N-end rule pathway (Fig. 5  A-D) . Thus, the autoprocessing of calpains can control them by making active calpains short-lived. The activation of calpains under conditions of traumatic or hypoxic brain injury is accompanied by the in vivo autoproteolysis of calpain-1 and has been shown to result in a preferential degradation of the autotruncated calpain-1 (54), the latter finding being in agreement with our data (Figs. 3F and 5 A-D and Fig. S1B ). Given the current uncertainty about biological roles of catalytically active calpain fragments (Results), key questions for future studies in this domain include the extent of calpain autoproteolysis in vivo under normal or stressful conditions; the contribution of resulting calpain fragments to the overall proteolytic activity of a specific calpain; and the role of the Arg/N-end rule pathway in the degradation of natural calpain fragments.
Both our findings and the earlier understanding of the dynamics of protein fragments vis-à-vis the Arg/N-end rule pathway (7, 9, 12, 14, 23) indicate that the topologically unique nature of N-degrons (their main determinant is a single N-terminal residue) has significantly contributed to coevolution of nonprocessive proteases and their cleavage sites in cellular proteins. As described above, these cleavage sites tend to be conserved in evolution, and their P1′ residues often yield C-terminal fragments whose N-terminal residues are recognized by the Arg/N-end rule pathway (Figs. 1A, 2, 4, and 5). Moreover, although the exact identity of a P1′ residue in a cleavage site can change during evolution, the residue's destabilizing nature is virtually always retained (Fig. 3 and Fig. S1 ), suggesting that a short in vivo half-life of a fragment (rather than the exact identity of its N-terminal residue) is a fitness-increasing property of this fragment, favored by natural selection.
In sum, the degradation of protease-generated protein fragments by the Arg/N-end rule pathway (Fig. 1A) has been identified as a significant part of cellular regulation. Examples, in addition to the present results (Figs. 1-6 ), include the aforementioned maintenance of the fidelity of chromosome cohesion/segregation and the function of the Arg/N-end rule pathway in repressing apoptosis and neurodegeneration (10, 12, 14) . Another example is the control of error-prone DNA synthesis, a part of DNA damage response. The Usp1 deubiquitylase (its functions include the control of DNA replication through unrepaired DNA lesions) can cleave itself but remains, transiently, an active deubiquitylase, as the two fragments of self-cleaved Usp1 stay together for some time (14, 55) . The C-terminal fragment of the self-cleaved Usp1 has been shown to be a short-lived physiological substrate of the Arg/ N-end rule pathway (14) . The rate of processive degradation of this fragment may act as a timer that determines the rate of cessation of deubiquitylation by self-cleaved Usp1.
An Nt-acetylated protein fragment is a potential target of the Ac/N-end rule pathway (Fig. 1B) (23, 24 ). An Nt-acetylated N-terminal fragment can be produced posttranslationally, by a calpain or another nonprocessive protease upon cleavage of a cotranslationally Nt-acetylated full-length protein. This cleavage would also yield a C-terminal fragment, the one that can be recognized and degraded by the Arg/N-end rule pathway, as described in the present study (Figs. 2-6 ). In addition, a C-terminal fragment bearing an N-terminal residue that is permissive for Ntacetylation (25) may be posttranslationally Nt-acetylated and thereby become a substrate of the Ac/N-end rule pathway. The latter possibility remains to be addressed experimentally.
The ability of the Arg/N-end rule and Ac/N-end rule pathways ( Fig. 1) to target proteins for degradation by recognizing their destabilizing N-terminal residues is a unique attribute of these pathways vis-à-vis the rest of the Ub system. This capability, in conjunction with the subunit selectivity of proteolysis by the N-end rule pathway (9, 53), plays a major role in protein remodeling through the selective elimination of protein fragments from oligomeric complexes in which these fragments are generated and transiently reside. Nonprocessive intracellular proteases that produce such fragments include calpains, caspases, separases, and secretases. The regulated destruction of protein fragments is likely to underlie a number of diverse biological functions of the N-end rule pathway that are cited in the Introduction. Many of these functions have been discovered through genetic (nonmechanistic) approaches. Fragments produced through cleavages by calpains are a major part of natural protein fragments under both normal and stressful conditions. The present results will facilitate the functional understanding of the striking diversity of calpain-generated fragments in the context of the N-end rule pathway ( Fig. 2 and Introduction) . Most of these fragments are still understood in descriptive (nonfunctional) terms.
Materials and Methods
Plasmids, cDNAs, and Primers. URT-based plasmids and other plasmids, constructed by standard methods, are described in Table S1 . PCR primers are described in Table S2 . Specific cDNAs encoding test proteins of the present study were either amplified from mouse cDNA libraries or purchased from Open Biosystems.
In Vitro and in Vivo Degradation Assays. The in vitro transcription-translationdegradation assays used the TNT T7 Coupled Transcription/Translation System (Promega) (11) . Human HEK293T cells were transfected with specific plasmids using Lipofectamine-2000 (Invitrogen).
These and other technical details of the present study are described in SI Materials and Methods. Regulated degradation of proteins or their fragments by the N-end rule pathway mediates a strikingly broad range of biological functions, including the sensing of heme, nitric oxide, oxygen, and short peptides; the control, through subunit-selective degradation, of the input stoichiometries of subunits in oligomeric protein complexes; the elimination of misfolded or otherwise abnormal proteins; the degradation of specific proteins after their retrotranslocation to the cytosol from mitochondria or other membraneenclosed compartments; the repression of apoptosis and neurodegeneration; the regulation of chromosome transcription, repair, replication, and cohesion/segregation; the regulation of G proteins, autophagy, peptide import, meiosis, immunity, fat metabolism, cell migration, actin filaments, cardiovascular development, spermatogenesis, neurogenesis, and memory; and the regulation of many processes in plants . In eukaryotes, the N-end rule pathway consists of two branches (A and B) . Part A. The Arg/N-end rule pathway: the prefix Arg in the pathway's name refers to N-terminal arginylation (Nt-arginylation) of N-end rule substrates, a significant feature of this system. The Arg/N-end rule pathway targets specific unacetylated N-terminal residues. In the yeast S. cerevisiae, the Arg/N-end rule pathway is mediated by the Ubr1 N-recognin, a 225-kDa RING-type E3 Ub ligase and a part of the targeting apparatus comprising a complex of the Ubr1-Rad6 and Ufd4-Ubc4/5 holoenzymes (1, 4, 9) . In multicellular eukaryotes, several functionally overlapping E3 Ub ligases (Ubr1, Ubr2, Ubr4, and Ubr5) function as N-recognins of this pathway. An N-recognin binds to the primary destabilizing N-terminal residues Arg, Lys, His, Leu, Phe, Tyr, Trp, and Ile. In contrast, the N-terminal Asn, Gln, Asp, and Glu residues (as well as Cys under some metabolic conditions) are destabilizing owing to their preliminary enzymatic modifications. These modifications include the Nt-deamidation of N-terminal Asn and Gln by the Ntan1 and Ntaq1 Nt-amidases, respectively, and the Nt-arginylation of N-terminal Asp and Glu by the Ate1 arginyltransferase (R-transferase), which can also Nt-arginylate oxidized Cys, either Cys-sulfinate or Cys-sulfonate. These derivatives of N-terminal Cys can form through oxidation of Cys by NO and oxygen, as has been shown by studies with Cys-based physiological N-end rule substrates in animal and plant cells. In addition to its type 1 and type 2 binding sites that recognize, respectively, the basic and bulky hydrophobic destabilizing N-terminal residues, an N-recognin such as Ubr1 contains other substrate-binding sites as well. These sites recognize substrates that are targeted through their internal (non-N-terminal) degrons, as indicated on the diagram (1). Hemin (Fe 3+ -heme) binds to the Ate1 R-transferase, inhibits its Nt-arginylation activity, and accelerates its in vivo degradation. Hemin also binds to Ubr1 (and apparently to other N-recognins as well) and alters its functional properties, in ways that remain to be understood (13) . It was recently shown that both yeast and mammalian Ubr1 can recognize not only the unacetylated primary destabilizing N-terminal residues cited above, but also the unacetylated N-terminal Met residue, if it is followed by a hydrophobic residue. This capability of the Arg/N-end rule pathway greatly expands the range of its substrates, as virtually all nascent proteins bear N-terminal Met (59) . This aspect of the Arg/N-end rule pathway is not depicted in the diagram, as it has been characterized thus far only in Saccharomyces cerevisiae (59) . Part B. The Ac/N-end rule pathway: The diagram illustrates the mammalian Ac/N-end rule pathway through extrapolation from its S. cerevisiae version. [Although it is virtually certain that this pathway is present in all eukaryotes (1), it has been characterized thus far only in S. cerevisiae (59-61)]. Red arrow on the left indicates the removal of N-terminal Met by Met-aminopeptidases (MetAPs). N-terminal Met is retained if a residue at position 2 is nonpermissive (too large) for MetAPs. If the retained N-terminal Met or N-terminal Ala, Ser, and Thr are followed by acetylation-permissive residues, the above N-terminal residues are Nt-acetylated by ribosome-associated Nt-acetylases (62-64). Nt-terminal Val and Cys are Nt-acetylated relatively rarely, whereas N-terminal Pro and Gly are almost never Nt-acetylated. N-degrons of the Ac/N-end rule pathway are called Ac/N-degrons to distinguish them from other N-degrons (1). The term secondary refers to the Nt-acetylation of a destabilizing N-terminal residue before a protein can be recognized by a cognate N-recognin. Natural Ac/N-degrons are regulated by their reversible steric shielding in protein complexes (59, 60) .
Supporting Information
Detailed (Extended) Legend to Fig. 2 . Calpain-generated C-terminal fragments of mammalian proteins that are either identified or predicted substrates of the Arg/N-end rule pathway.
The entries whose numbers are colored in green are the experimentally identified (most of them in the present study) substrates of the Arg/N-end rule pathway. The entries whose numbers are colored in black are predicted Arg/N-end rule substrates. Each entry cites a calpain-generated C-terminal (Ct) fragment of a protein and the fragment's N-terminal residue (in red, using three-letter abbreviations for amino acids), followed by a description of uncleaved (full-length) precursor protein. A calpain cleavage site, denoted by an arrowhead, uses single-letter abbreviations for amino acids. An enlarged P1′ residue (in red) becomes N-terminal upon the cleavage. The indicated residue numbers are the number of the first shown residue of a fulllength protein and the number of its last residue, respectively. All entries are mouse proteins, with the exception of #14 and #27, which are human proteins. #1: Glu-Bak is the proapoptotic Ct fragment of the apoptotic regulator BAK. Glu-BAK is generated by calpain-1 in vitro and is apparently formed in vivo as well (65) (Figs. 3A and 5 E and F) . #2: Arg-Bid. Bid is a 22-kDa member of the BCL-2 family of apoptosis regulators (66) (67) (68) . Although full-length Bid is a proapoptotic factor, its C-terminal fragments, which can be naturally produced by activated caspases, calpains or granzyme B, can be even more active than intact Bid as proapoptotic proteins (69) . The cleavage of Bid by calpains produces the 14-kDa Arg71-Bid fragment (69-72) that has been shown by us to be a short-lived substrate of the Arg/N-end rule pathway (23) . #3: Asp-Bcl XL . Bcl XL is a 26-kDa antiapoptotic regulatory protein (66, 73) . Under conditions that include glucose and oxygen deprivation, Bcl XL can be cleaved by activated calpain-1, resulting in the 21-kDa Asp61-Bcl XL fragment. In contrast to full-length Bcl XL , the Asp61-Bcl XL fragment has proapoptotic activity (74) and has been shown by us to be a short-lived substrate of the Arg/N-end rule pathway (23) . #4: Arg-c-Fos is the Ct fragment of the c-Fos transcriptional regulator. c-Fos is targeted for conditional degradation through more than one degron, including the path that includes the cleavage by calpains (75) (Fig. S1A and Fig.  5 K and L). #5: Glu-IκBα is the Ct fragment of the IκBα subunit of the NFκB-IκBα complex in which the NFκB transcriptional regulator is inhibited by IκBα. The IκBα subunit is targeted for degradation either through a conditional phosphodegron or through a specific calpain-mediated cleavage (76) (Figs. 3C and 5 I and J). #6: Arg-Igfbp2 is the calpain-generated Ct fragment of the insulin-like growth factor binding protein-2 (77) (Fig. S1C and Fig. 5 G and H /calmodulin or by the calpain-mediated truncation of Atp2b2 that generates the Lys-Atp2b2 fragment and thereby activates the pump (80) (Fig. S1E and Fig. 4 J and K) . #9: LeuCapn1 is the natural autogenerated, catalytically active Ct fragment of calpain-1 (81, 82) (Fig. S1B and Fig. 5 C and D) . #10: ArgAnkrd2. Ankrd2 (Marp2, Arpp), a member of the MARP (muscle ankyrin repeat protein) family, functions as a negative regulator of muscle differentiation (83) . Calpains can produce the 30-kDa Arg103-Ankrd2 fragment (84) (Figs. 3E and 4 F and G) . #11: TyrGrm1. Grm1 is the Ct fragment of the mGluR1α transmembrane metabotropic glutamate receptor (85) . Receptors containing the calpain-truncated mGluR1α subunit could elevate cytosolic Ca 2+ but could not activate PI 3 K-Akt signaling pathways, in contrast to uncleaved receptors (85, 86) (Figs. 3B and 4 H and I). #12: LysIca512. Ica512 (Ptprn) is a member of the transmembrane receptor protein phosphatase family (87) . The 43-kDa calpain-generated mouse Lys609-Ica512 fragment enters the nucleus and acts as a transcriptional regulator (87, 88) (Fig. S1D and Fig. 4 D and E). #13: Phe-GluN2a. GluN2a (NMDA-R2a) is a subunit of the NMDA receptor (NMDAR), a glutamate receptor that can function as a ligand-gated Ca 2+ channel (89, 90) . The GluN2b subunit of NMDAR can also be cleaved by calpains (91) . Ct fragments of NR2A and NR2B contain domains required for the association of these subunits with other synaptic proteins. NMDAR receptors lacking the Ct region of GluN2a could function as glutamate-gated Ca 2+ channels but the intracellular traffic of cleaved receptors, and their electrophysiological properties were altered (92) (Figs. 3D  and 4 B and C). #14: Asn-DSCR1 (Rcan1) is the calpain-generated Ct fragment of the Down syndrome critical region 1 protein Dscr1, which binds to Raf1, inhibits the phosphatase activity of calcineurin, and enhances its degradation. The Asn-DSCR1 fragment does not bind to the Raf1 kinase (93) . #15: Arg-Glyt1a is the Ct fragment of the transmembrane Glyt1a glycine transporter (94) . Another Gly transporter, Glyt1b, is also cleaved by calpains, yielding the Arg-Glyt1b fragment (94) . These Ct fragments are still active as transporters but are impaired in their ability to remove Gly (an inhibitory neurotransmitter) from synaptic clefts (94) . #16: Asn-Ca v 1.1 is the Ct fragment of the voltage-gated transmembrane Ca 2+ channel. This (apparently) calpain-generated fragment is noncovalently associated with the rest of the channel and can inhibit its activity. Upon dissociation from the channel, the AsnCa v 1.1 fragment enters the nucleus and functions as a transcriptional regulator (95) (96) (97) (98) . #17: Lys-cortactin is the Ct fragment of cortactin, an actin-binding protein that regulates actin polymerization (99) . #18: Asn-Bfl-1. Bfl-1 is antiapoptotic regulatory protein whose cleavage by calpain-1 generates the Asn72-Bfl-1 Ct proapoptotic fragment (100). #19: Arg-dystrophin is the calpain-generated Ct fragment of a major cytoskeletal protein in the skeletal muscle (101) . #20: Gln-Ryr1 is the Ct fragment of the Ryr1 ryanodine receptor, a Ca 2+ channel in the ER (102) that mediates the efflux of Ca 2+ from the ER into the cytosol. Calpain-mediated cleavage of Ryr1 increases Ca 2+ efflux (103) . #21: Arg-Mef2d is the Ct fragment of the Mef2d myocyte enhancer factor 2d, a transcriptional regulator that contributes to neuronal survival, development, and synaptic plasticity (104) . #22: Gln-talin is the calpain-generated Ct fragment of talin, an adaptor protein that interacts with the integrin family of cell adhesion transmembrane proteins (80, 105, 106) . #23: Arg-p39 is the calpain-generated Ct fragment of the p39 activator of the Cdk5 protein kinase (107) . The indicated cleavage site is located immediately downstream of two other closely spaced (and strongly conserved) calpain cleavage sites in p39. A cleavage at any one of these sites yields a predicted Arg/N-end rule substrate. #24: Gln-Egfr is one of calpain-generated Ct fragments of the transmembrane epidermal growth factor (EGF) receptor protein kinase (108) . Remarkably, all seven calpain cleavage sites in the cytosol-exposed domain of the 170-kDa EGFR contain P1′ residues that are destabilizing in the Arg/N-end rule (108) . #25: Leu-β-catenin is the calpain-generated Ct-fragment of β-catenin, a conditionally short-lived cytoskeletal protein and transcriptional regulator. The Leu-β-catenin fragment is a nuclear protein that activates specific genes in conjunction with other transcription factors (109) . #26: Leu-NF2 is the calpain-generated Ct fragment of NF2 (merlin), a tumor suppressor and cytoskeletal protein. Loss of function NF2 mutants result in autosomal-dominant neurofibromatosis, a predisposition to specific kinds of brain tumors (110) . #27: Arg-caspase-9 is the Ct fragment of caspase-9, which can be inactivated by calpains (111), followed by the (predicted) degradation of the Arg-caspase-9 fragment by the Arg/N-end rule pathway. #28: Leu-troponin T2 is the Ct fragment of the cardiac troponin T that is produced by calpain-1 in the troponin-containing cardiac myofibril complex (112) . #29: Lys-PKCα is the calpain-generated Ct fragment of PKCα, a broadly expressed Ser/Thr kinase of the PKC family (113) . Being catalytically active but no longer controlled by the regulatory Nt domain of the full-length PKCα, the Lys-PKCα fragment can be toxic, for example, upon its formation in an ischemic heart (114). #30: Leu-Rad21 is the calpain-generated Ct-fragment of the Scc1/ Rad21 subunit of the chromosome-associated cohesin complex (115) . The calpain-mediated generation of Leu-Rad21 contributes to the control of chromosome cohesion/segregation, together with processes that include the separase-mediated cleavage of the same Rad21 subunit (32, (115) (116) (117) . #31: Phe-PKCγ is the calpain-generated Ct fragment of PKCγ, a Ser/Thr kinase of the PKC family (113) . The Phe-PKCγ fragment is constitutively active as a kinase, because it lacks the regulatory Nt domain of the full-length PKCγ kinase (113) . #32: Leu-STEP 33 is the Ct fragment of the striatal-enriched STEP 61 phosphatase, a brain-specific Tyr-phosphatase whose substrates include the MAPK-family kinases ERK1/2 and p38. The calpain-generated Leu-STEP 33 fragment lacks phosphatase activity (118) . #33: LeuCamk-IV is the calpain-generated Ct fragment of the Ca 2+ /calmodulin-dependent kinase-IV. This fragment lacks kinase activity (119) . #34: Leu-vimentin is the calpain-generated Ct fragment of vimentin, a component of intermediate filaments (120) .
SI Materials and Methods
Miscellaneous Reagents. Cycloheximide and calcium ionophore A23187 were from Sigma. Calpain inhibitor carbobenzoxyvalinyl-phenylalaninal (zVF) was from Calbiochem. Mouse and human cDNAs encoding proteins examined in the present work were from OpenBiosystems. Anti-flag M2 Magnetic Beads (M8823; Sigma) were used for immunoprecipitation. Immunoblotting was carried out using the anti-flag monoclonal mouse M2 antibody (Sigma), the HRP-conjugated goat antimouse antibody (#170-6516; BioRad), and ECL Prime Western Blotting Detection System (GE Healthcare), according to the manufacturers' protocols.
Plasmids, cDNAs, and Primers. Turbo Escherichia coli [New England Biolabs (NEB)] was used for cloning and maintaining plasmids. Phusion High-Fidelity DNA polymerase (NEB) was used for PCR. All constructed plasmids were verified by DNA sequencing.
In some Ub reference technique (URT)-based assays, a test protein migrated, upon SDS/PAGE, too close to the standard DHFR-Ub reference moiety (Fig. 4A) . Therefore, a larger version of the reference moiety was constructed for such cases (Fig. 5 I and K) , through an extension of DHFR-Ub with an N-terminal region of the E. coli β-galactosidase (βgal; residues 25-119). A DNA fragment encoding this region of βgal was amplified using the plasmid pKP55-M (Table S1 ) as a template and primers 1605 and 1606 (Table S2 ). The resulting fragment was digested with HindIII and BamHI, and cloned into HindIII/BamHI-cut pKP496, yielding pKP582. It contained a region encoding the N-terminal flag tag and f βgal-DHFR-Ub
R48
, followed by the multiple cloning site (MCS) SacII-EcoRI-XhoI-ClaI-EcoRV. The pKP582 plasmid was a precursor of some plasmids encoding specific URT-based protein fusions (Table S1 ). GluN2a. The mouse GluN2a ORF was amplified from a mouse brain cDNA library using primers 1585 and 1587 for Phe1279-GluN2a or 1586 and 1587 for Val1279-GluN2a (Table S2 ). The resulting DNA fragments were cut with SacII and ClaI and cloned into SacII/ClaI-cut pKP496 (Table S1 ), yielding pKP568 and pKP569, respectively. Ica512. The mouse Ica512 ORF was amplified using cDNA from OpenBiosystems (ID: 4987532) and primers 1591, 1593, 1597, and 1598 for the Lys611-Ica512 protein fragment or 1592, 1593, 1597, and 1598 for the Val611-Ica512 fragment (Table S2 ). The resulting DNA fragments were cut with SacII and ClaI and cloned into SacII/ClaI-cut pKP496, yielding pKP574 and pKP575, respectively. Full-length mouse Ica512 bearing both N-terminal and C-terminal flag tags and an alternative junctional residue (Val) at the calpain cleavage site (they were termed f -K609V fulllength protein (Table S2 ). The resulting DNA fragments were cut with HindIII and AfeI and were cloned into HindIII/AfeI-cut pKP574, yielding pKP599 and pKP600, respectively (Table S1 ). Ankrd2. The mouse Ankrd2 ORF was amplified using cDNA from OpenBiosystems (ID: 8861782) and primers 1570 and 1572 for the Arg103-Ankrd2 fragment or 1571 and 1572 for the Val103-Ankrd2 fragment. The resulting DNA fragments were cut with SacII and ClaI and cloned into SacII/ClaI-cut pKP496, yielding pKP576 and pKP577, respectively (Table S1 ). Grm1. The mouse Grm1 ORF was amplified using cDNA from OpenBiosystems (ID: 30544252) and primers 1579 and 1581 for the Tyr937-GRM1 fragment or 1580 and 1581 for the Val937-GRM1 fragment. The resulting DNA fragments were cut with SacII and ClaI and cloned into SacII/ClaI-cut pKP496, yielding pKP564 and pKP565, respectively (Table S1 ). Atp2b2. The mouse Atp2B2 ORF was amplified from the above mouse cDNA library using primers 757 and 759 for the Arg1091-Atp2b2 fragment or 758 and 759 for the Val1091-ATP2B2 fragment. The resulting DNA fragments were cut with SacII and EcoRV and cloned into SacII/ EcoRV-cut pKP496, yielding pJO386 and pJO387, respectively (Table S1 ). Capns1. The mouse Capns1 ORF was amplified from the above mouse cDNA library using primers 1576 and 1578 for the Asp142-CAPNS1 fragment or 1577 and 1578 for the Val142-Capns1 fragment. The resulting DNA fragments were cut with SacII and ClaI and cloned into SacII/ClaI-cut pKP496, yielding pKP578 and pKP579, respectively (Table S1 ). Capn1. The human Capn1 ORF was amplified using cDNA from OpenBiosystems (ID: 5223130) and primers 1510, 1512, 1513, and 1490 for the Leu28-Capn1 fragment or 1511, 1512, 1513, and 1490 for the Val28-Capn1 fragment. The resulting DNA fragments were cut with SacII and ClaI and cloned into SacII/ClaI-cut pKP496, yielding pKP536 and pKP537, respectively (Table S1 ). Bak. The mouse Bak ORF was amplified from the above mouse cDNA library using primers 1610 and 1612 for the Glu16-Bak fragment or 1611 and 1612 for the Val16-Bak fragment. The resulting DNA fragments were cut with SacII and ClaI and cloned into SacII/ClaI-cut pKP496, yielding pKP583 and pKP584, respectively (Table S1 ). Igfbp2. The mouse Igfbp2 ORF was amplified from a mouse cDNA library using primers 1582 and 1584 for the Arg181-IgfbP2 fragment or 1583 and 1584 for the Val181-IgfbP2 fragment. The resulting DNA fragments were cut with SacII and ClaI and cloned into SacII/ClaI-cut pKP496, yielding pKP566 and pKP567, respectively (Table S1 ). IkBα. The mouse IκBα ORF was amplified from the above mouse cDNA library using primers 763 and 765 for the Glu51-IκBα fragment or 764 and 765 for the Val51-IκBα fragment. The resulting DNA fragments were cut with SacII and ClaI and cloned into SacII/ClaI-cut pKP582, yielding pJO427 and pJO428, respectively (Table S1) . c-Fos. The mouse c-Fos ORF was amplified using cDNA from OpenBiosystems (ID: 2582234) and primers 760 and 762 for the Arg91-c-Fos fragment or 761 and 762 for the Val91-cFOS fragment. The resulting DNA fragments were cut with SacII and ClaI and cloned into SacII/ClaI-cut pKP582, yielding pJO425 and pJO426, respectively (Table S1 ).
In Vitro Transcription-Translation-Degradation Assays. The TNT T7 Coupled Transcription/Translation System, a version of the Promega's rabbit reticulocyte extract preparation in which the main components of the system were supplied separately, was used to carry out transcription-translation-degradation assays (23, 24, 121) . Reaction samples were prepared according to the manufacturer's instructions. Nascent proteins in reticulocyte extract were pulse-labeled with [ 35 S]L-methionine (0.55 mCi/mL, 1,000 Ci/mmol, MP Biomedicals) for 10 min at 30°C, in the total volume of 30 μL. The labeling was quenched by the addition of cycloheximide and unlabeled methionine to the final concentrations of 0.1 mg/mL and 5 mM, respectively. Samples were withdrawn at indicated time points of a chase. The reactions were terminated by the addition of 0.1 mL of TSD buffer (1% SDS, 5 mM DTT, 50 mM Tris·HCl, pH 7.4) and snap-freezing samples in liquid nitrogen. Samples were then heated at 95°C for 10 min, diluted with 10 volumes of TNN buffer (0.5% Nonidet P-40, 0.25 M NaCl, 5 mM EDTA, 50 mM Tris·HCl, pH 7.4), containing the complete protease-inhibitor mixture (Roche), clarified by centrifugation at 20,000 × g for 5 min, and immunoprecipitated using 5 μL of anti-flag M2 Magnetic Beads. The samples were incubated with rocking at 4°C for 3 h, followed by three washes in TNN buffer, one wash in 10 mM Tris·HCl (pH 8.5), and resuspension in 20 μL of SDS-sample buffer. The resulting samples were heated at 95°C for 5 min and fractionated by SDS 4-12% PAGE, followed by autoradiography and quantification, using Storm PhosphorImager (Molecular Dynamics) and ImageQuant (GE Healthcare).
In Vivo URT-Based Degradation Assays. Human HEK293T cells were obtained from American Type Culture Collection (ATCC). Cells were grown at 37°C with 5% (vol/vol) CO 2 in DMEM supplemented with 10% FBS (Gemini Bio-Products) and penicillin/ streptomycin (100 units/mL) (HyClone). Cells were transfected at ∼75% confluency with 0.05-0. 
